Register entry
Vanda Pharmaceuticals Inc.
- Registered sites
- 0
- Drug products
- 38
- Live patents
- 259
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
259Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| BYSANTI | MILSAPERIDONE | Mar 2028 |
| BYSANTI | MILSAPERIDONE | Apr 2030 |
| BYSANTI | MILSAPERIDONE | Jul 2030 |
| BYSANTI | MILSAPERIDONE | Sept 2030 |
| BYSANTI | MILSAPERIDONE | Oct 2030 |
| BYSANTI | MILSAPERIDONE | Dec 2030 |
| BYSANTI | MILSAPERIDONE | Jan 2031 |
| BYSANTI | MILSAPERIDONE | Feb 2031 |
| BYSANTI | MILSAPERIDONE | Dec 2031 |
| BYSANTI | MILSAPERIDONE | May 2044 |
| FANAPT | ILOPERIDONE | Nov 2027 |
| FANAPT | ILOPERIDONE | Mar 2028 |
| FANAPT | ILOPERIDONE | Apr 2030 |
| FANAPT | ILOPERIDONE | Jul 2030 |
| FANAPT | ILOPERIDONE | Aug 2030 |
| FANAPT | ILOPERIDONE | Sept 2030 |
| FANAPT | ILOPERIDONE | Oct 2030 |
| FANAPT | ILOPERIDONE | Dec 2030 |
| FANAPT | ILOPERIDONE | Jan 2031 |
| FANAPT | ILOPERIDONE | Feb 2031 |
| FANAPT | ILOPERIDONE | Dec 2031 |
| HETLIOZ | TASIMELTEON | Jan 2033 |
| HETLIOZ | TASIMELTEON | Apr 2033 |
| HETLIOZ | TASIMELTEON | May 2034 |
| HETLIOZ | TASIMELTEON | Oct 2034 |
| HETLIOZ | TASIMELTEON | Feb 2035 |
| HETLIOZ | TASIMELTEON | Jul 2035 |
| HETLIOZ | TASIMELTEON | Aug 2035 |
| HETLIOZ | TASIMELTEON | Feb 2041 |
| HETLIOZ LQ | TASIMELTEON | Jan 2033 |
| HETLIOZ LQ | TASIMELTEON | Apr 2033 |
| HETLIOZ LQ | TASIMELTEON | May 2034 |
| HETLIOZ LQ | TASIMELTEON | Oct 2034 |
| HETLIOZ LQ | TASIMELTEON | Feb 2035 |
| HETLIOZ LQ | TASIMELTEON | Jul 2035 |
| HETLIOZ LQ | TASIMELTEON | Aug 2035 |
| HETLIOZ LQ | TASIMELTEON | Dec 2040 |
| HETLIOZ LQ | TASIMELTEON | Feb 2041 |
| NEREUS | TRADIPITANT | Mar 2036 |
| NEREUS | TRADIPITANT | Aug 2036 |
| PONVORY | PONESIMOD | Nov 2029 |
| PONVORY | PONESIMOD | May 2032 |
| PONVORY | PONESIMOD | Dec 2035 |
| PONVORY | PONESIMOD | Oct 2042 |
Catalogue
Marketed products
38Showing 38 of 38.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | KIT | NDA |
| BYSANTI | MILSAPERIDONE | KIT | NDA |
| BYSANTI | MILSAPERIDONE | KIT | NDA |
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | TABLET | NDA |
| BYSANTI | MILSAPERIDONE | KIT | NDA |
| BYSANTI | MILSAPERIDONE | KIT | NDA |
| BYSANTI | MILSAPERIDONE | KIT | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | KIT | NDA |
| FANAPT | ILOPERIDONE | KIT | NDA |
| FANAPT | ILOPERIDONE | KIT | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | KIT | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | TABLET | NDA |
| FANAPT | ILOPERIDONE | KIT | NDA |
| FANAPT | ILOPERIDONE | KIT | NDA |
| Hetlioz | tasimelteon | CAPSULE | NDA |
| Hetlioz LQ | tasimelteon | SUSPENSION | NDA |
| NEREUS | TRADIPITANT | CAPSULE | NDA |
| PONVORY | Ponesimod | KIT | NDA |
| PONVORY | Ponesimod | TABLET, FILM COATED | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.